Philadelphia Trust Company’s Colgate-Palmolive CL Stock Holding History

Philadelphia Trust Company’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$429K	Sell	5,029 -1,315	-21%	-$117K	0.03%	172
2025 Q4	$501K	Sell	6,344 -1,364	-18%	-$107K	0.03%	159
2025 Q3	$616K	Sell	7,708 -12,980	-63%	-$1.11M	0.04%	141
2025 Q2	$1.88M	Sell	20,688 -42,057	-67%	-$3.84M	0.14%	84
2025 Q1	$5.88M	Sell	62,745 -22,715	-27%	-$2.03M	0.5%	46
2024 Q4	$7.77M	Sell	85,460 -8,706	-9%	-$831K	0.57%	45
2024 Q3	$9.78M	Sell	94,166 -3,872	-4%	-$395K	0.71%	36
2024 Q2	$9.51M	Sell	98,038 -52,642	-35%	-$4.86M	0.74%	37
2024 Q1	$13.6M	Sell	150,680 -47,239	-24%	-$4M	1.09%	23
2023 Q4	$15.8M	Buy	197,919 +7,914	+4%	+$595K	1.48%	16
2023 Q3	$13.5M	Sell	190,005 -641	-0.3%	-$47.9K	1.39%	17
2023 Q2	$14.7M	Buy	190,646 +108,911	+133%	+$8.43M	1.39%	16
2023 Q1	$6.14M	Buy	81,735 +75,373	+1,185%	+$5.6M	0.63%	50
2022 Q4	$501K	Hold	6,362	–	–	0.05%	151
2022 Q3	$447K	Hold	6,362	–	–	0.05%	151
2022 Q2	$510K	Sell	6,362 -66	-1%	-$5.16K	0.05%	146
2022 Q1	$487K	Buy	6,428 +235	+4%	+$18.6K	0.04%	168
2021 Q4	$529K	Sell	6,193 -250	-4%	-$19.5K	0.04%	167
2021 Q3	$487K	Sell	6,443 -499	-7%	-$39.6K	0.04%	172
2021 Q2	$565K	Sell	6,942 -992	-13%	-$81.1K	0.04%	171
2021 Q1	$625K	Sell	7,934 -850	-10%	-$66.6K	0.05%	154
2020 Q4	$751K	Hold	8,784	–	–	0.06%	135
2020 Q3	$678K	Sell	8,784 -60,595	-87%	-$4.62M	0.07%	131
2020 Q2	$5.08M	Buy	69,379 +63,395	+1,059%	+$4.5M	0.54%	50
2020 Q1	$397K	Sell	5,984 -1,495	-20%	-$105K	0.05%	125
2019 Q4	$515K	Buy	7,479 +30	+0.4%	+$2.04K	0.04%	158
2019 Q3	$548K	Buy	7,449 +5	+0.1%	+$363	0.05%	155
2019 Q2	$534K	Sell	7,444 -82,148	-92%	-$5.83M	0.05%	156
2019 Q1	$6.14M	Buy	89,592 +83,641	+1,405%	+$5.4M	0.54%	58
2018 Q4	$354K	Sell	5,951 -970	-14%	-$60.7K	0.04%	146
2018 Q3	$463K	Buy	6,921 +347	+5%	+$23.1K	0.04%	154
2018 Q2	$426K	Sell	6,574 -100	-1%	-$6.54K	0.04%	157
2018 Q1	$478K	Sell	6,674 -580	-8%	-$41.7K	0.04%	156
2017 Q4	$547K	Hold	7,254	–	–	0.04%	153
2017 Q3	$528K	Buy	7,254 +1,060	+17%	+$76.4K	0.04%	149
2017 Q2	$459K	Buy	6,194 +100	+2%	+$7.42K	0.04%	153
2017 Q1	$446K	Buy	6,094 +114	+2%	+$7.98K	0.04%	160
2016 Q4	$391K	Hold	5,980	–	–	0.03%	170
2016 Q3	$443K	Buy	5,980 +800	+15%	+$59.1K	0.04%	157
2016 Q2	$379K	Hold	5,180	–	–	0.03%	157
2016 Q1	$366K	Hold	5,180	–	–	0.03%	146
2015 Q4	$340K	Buy	5,180 +250	+5%	+$16.6K	0.03%	154
2015 Q3	$313K	Buy	4,930 +4,607	+1,426%	+$301K	0.03%	146
2015 Q2	$4.93K	Sell	323 -4,607	-93%	-$313K	0.02%	162
2015 Q1	$342K	Hold	4,930	–	–	0.03%	145
2014 Q4	$341K	Hold	4,930	–	–	0.03%	133
2014 Q3	$322K	Hold	4,930	–	–	0.02%	142
2014 Q2	$336K	Sell	4,930 -600	-11%	-$40.2K	0.02%	140
2014 Q1	$359K	Hold	5,530	–	–	0.02%	148
2013 Q4	$361K	Buy	5,530 +300	+6%	+$19.2K	0.02%	158
2013 Q3	$310K	Hold	5,230	–	–	0.02%	153
2013 Q2	$300K	Buy	+5,230	New	+$310K	0.02%	149

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Philadelphia Trust Company's CL Position: Q1 2026 in Review

Philadelphia Trust Company reduced its Colgate-Palmolive (CL) stake by 21% in Q1 2026, selling an estimated $117K and leaving 5,029 shares worth $429K. The position accounts for 0.03% of the portfolio, ranked #172.

Philadelphia Trust Company first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.8M in Q4 2023. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Philadelphia Trust Company held 5,029 shares of Colgate-Palmolive worth $429K as of Q1 2026.
Philadelphia Trust Company sold 1,315 Colgate-Palmolive shares in Q1 2026, an estimated $117K.
Colgate-Palmolive made up 0.03% of Philadelphia Trust Company's portfolio in Q1 2026, its #172 holding.
Philadelphia Trust Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Philadelphia Trust Company's Colgate-Palmolive position peaked at $15.8M in Q4 2023.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.